Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 70 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Visits mentioned: 3 visits
- Procedures mentioned: Questionnaires, Phone or video check-ins
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Participants will complete a total of three study visits: a baseline visit (which includes consent, screening, and enrollment procedures), a 16-week follow-up visit, and a 32-week follow-up visit."
- "In addition, participants will complete study surveys throughout the study period, which are expected to require approximately 30-40 minutes per survey."
- "Depending on study group assignment, participants may also use study devices and mobile applications to track health behaviors and/or participate in telehealth visits with a healthcare provider."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether digital health tools, with or without help from a health care provider, improve blood sugar and other diabetes outcomes in adults with type 2 diabetes. It also looks at whether these tools can fit into regular primary care and help guide care for each person.
The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have had type 2 diabetes for at least 1 year.
- Have an HbA1c result of 8% to 11% from the past 3 months. This blood test shows average blood sugar. The study will also check it with a quick test.
- Own a smartphone.
- Speak English or Spanish.
Who can't join
- Are pregnant.
- Are not available or willing to use a continuous glucose monitor (a device that tracks blood sugar) or the study device or digital tools.
- Have a serious medical condition or an active disorder that affects thinking, such as terminal cancer or schizophrenia.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * diagnosis of T2D for at least one year * recent 3 month-HbA1c, 8-11% * ownership of a smartphone * English or Spanish speaking. Exclusion Criteria: * pregnant * not available or willing to use CGM or study device/platform * serious medical conditions or active thought disorders (e.g., terminal cancer, schizophrenia) In addition to the self-report of the HbA1c within the past 3 months, potential participants will be screened with a point-of-care (POC) HbA1c (A1CNow®+).
Study sites (1)
CT
- Yale School of Nursing · New Haven, CT 06477More trials in New Haven